海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Autologous Bone Marrow Transplantation for Premature Ovarian Insufficiency
- Premature Ovarian Failure
- Egypt
- 2016-05-18
Not recruiting
- Phase IIa examination of the effect of oral dosing of NV-52 on surrogate markers of inflammatory bowel disease (IBD) in patients with stable disease but with a consistent abnormality in one or more surrogate marker.
- Crohn's disease and Ulcerative Colitis
- Australia
- 2007-11-29
Not Recruiting
- A study conducted in many hospitals, carried out in two groups of patients with advanced skin cancer who know that they are receiving the study medication and have previously received treatment for their advanced skin cancer and the disease has progressed since that treatment
- American Joint Committee on Cancer unresectable stage III or stage IV melanima and disease progression with subjects not harboring the V600E-BRAF mutation with disease progression following first line standard of care (cohort 1) or subjects harboring the V600E-BRAF mutation with disease progression following BRAF-V600E-targeted therapy (cohort 2). MedDRA version: 14.1 Level: PT Classification code 10025650 Term: Malignant melanoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Germany, United Kingdom, United States
- 2010-07-19
Not recruiting
- PROxIMO: Efficacy of proactive therapeutic drug monitoring and dose adjustment of infliximab based on point of care testing for inflammatory bowel disease
- Ulcerative Colitis;Crohn's Disease
- Australia
- 2016-08-04
Not Recruiting
- A study evaluating the effect of EVARREST™ Fibrin Sealant Patch as compared to Tachosil in controlling bleeding during cardivascular surgery
- subjects undergoing major aortic surgery, including ascending, arch, or descending aorta replacement, requiring adjunctive support for hemostasis at the anastomotic suture line;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
- Australia, Belgium, Japan, Russian Federation, United Kingdom, United States
- 2013-11-26
Not recruiting
- PK Study of Rifampicin Interactions With DMPA and Efaviranz in TB
- HIV-1 Infection;Tuberculosis;HIV-1 Infection;Tuberculosis;HIV-1 Infection;Tuberculosis
- Botswana, Kenya, South Africa, Zimbabwe
- 2015-03-17
Not recruiting
- A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
- Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF;Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF;Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF;Solid Tumors and Advanced Endometrial Cancer;Endometrial Cancer;Second-line Treatment;VEGF
- Brazil, Egypt, Italy, Korea, Republic of, New Zealand, Spain, United Kingdom, United States
- 2011-06-06
Not recruiting
- Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase
- Gaucher Disease;Gaucher Disease;Gaucher Disease;Gaucher Disease
- Australia, Canada, Israel, Serbia, Spain, United Kingdom, United States
- 2008-07-07
Not recruiting
- Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial
- Gaucher Disease;Gaucher Disease;Gaucher Disease;Gaucher Disease
- Australia, Canada, Chile, Israel, South Africa, Spain, United Kingdom, United States
- 2008-06-25
Not Recruiting
- Phase 3 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLC
- First-line treatment of metastatic NSCLC MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-11-07
Not Recruiting
- Phase 2 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLC
- First-line treatment of metastatic NSCLC MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-04
Not recruiting
- Effect of Nitric Oxide Donors on Uterine and Subendometrial Blood Flow in Patients With Unexplained Infertility
- Polycystic Ovary Syndrome;Infertility, Female;Polycystic Ovary Syndrome;Infertility, Female;Polycystic Ovary Syndrome;Infertility, Female
- Egypt
- 2018-03-19
Not Recruiting
- Worms and human immunodeficiency virus (HIV) Interaction Study - Epidemiology component
- Human immunodeficiency virus-1 (HIV-1) infection/helminth infections Infections and Infestations Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
- Tanzania
- 2009-08-19
Not Recruiting
- BRIM 3: A Randomized, Open-label, Controlled, Multicenter, Phase III Study in Previously untreated Patients with Unresectable Stage IIIC or Stage IV Melanoma with V600E BRAF mutation Receiving Vemurafenib (RO5185426) or Dacarbazine. - BRIM 3
- First-line therapy for adult patients with histologically confirmed metastatic melanoma (unresectable Stage IIIC or Stage IV) harbouring the V600E positive mutation MedDRA version: 17.0 Level: LLT Classification code 10027481 Term: Metastatic melanoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, France, Germany, Israel, Italy, Netherlands, New Zealand, Sweden, Switzerland, United Kingdom, United States
- 2009-10-29
Not recruiting
- A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491
- Dilated Cardiomyopathy;Dilated Cardiomyopathy;Dilated Cardiomyopathy
- Australia
- 2017-02-16
Not Recruiting
- Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer? Measuring subjective improvement as well as objective response to estimate the benefit of palliative chemotherapy in women with platinum resistant or refractory ovarian cancer
- Women with platinum resistant/refractory ovarian cancers who are about to start 2nd or subsequent line chemotherapy
- Australia, Europe, Japan, North America
- 2013-03-15
Not Recruiting
- A Phase III Study of STI571 Versus Interferon-a (IFN-a) Combined With Cytarabine (Ara-C) in Patients With Newly Diagnosed Previously Untreated Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
- Chronic Myelogenous Leukemia;C92.1 - Chronic myeloid leukaemia [CML], BCR/ABL-positive
- Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, United States
- 2012-05-09
Not recruiting
- A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
- Chronic Hepatitis C;Human Immunodeficiency Virus;Chronic Hepatitis C;Human Immunodeficiency Virus;Chronic Hepatitis C;Human Immunodeficiency Virus;Chronic Hepatitis C;Human Immunodeficiency Virus
- Australia, France, Germany, Italy, Portugal, Spain, United Kingdom
- 2013-01-31
Not Recruiting
- A study of the safety and effectiveness of a new treatment from human blood source that replaces the missing clotting factor VIII, including determination of drug level in hemophilia A patients.
- Hemophilia A. MedDRA version: 17.1 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 100000004850 ;Therapeutic area: Body processes [G] - Genetic Phenomena [G05]
- Australia, Austria, Canada, Chile, Czech Republic, European Union, Germany, Hungary, Italy, Japan, Korea, Republic of, Lebanon, Malaysia, Netherlands, Philippines, Poland, Russian Federation, South Africa, Spain, Sweden, Switzerland, Ukraine, United Kingdom, United States
- 2011-07-28
Not Recruiting
- Albiglutide Versus Placebo as Add-on to Intensified Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Mellitus
- Diabetes mellitus type 2 MedDRA version: 17.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Brazil, Canada, France, Germany, Hungary, Italy, Korea, Republic of, Mexico, Philippines, Poland, South Africa, Spain, United Kingdom, United States
- 2014-10-01